-
Innovation Ranking
Innovation Ranking – AcelRx Pharmaceuticals Inc
AcelRx Pharmaceuticals Inc (AcelRx), is a specialty pharmaceutical company that develops and commercializes drugs for the treatment of pain. The company’s lead product candidate, Dsuvia (known as Dzuveo in Europe), is a single sufentanil sublingual tablet for treating of moderate-to-severe acute pain. Its pipeline also includes Zalviso (for US market), a drug and device combination product for the management of moderate to severe acute pain in adults. AcelRx developed a proprietary, non-invasive, sublingual formulation technology to deliver its highly lipophilic...
-
Product Insights
NewPancreatic Diseases – Drugs In Development, 2024
Empower your strategies with our Pancreatic Diseases – Drugs In Development, 2024 report and make more profitable business decisions. Pancreatic diseases encompass a range of conditions that affect the pancreas, a vital organ located behind the stomach. The pancreas plays a crucial role in digestion and hormone regulation by producing enzymes for digestion and hormones like insulin and glucagon that regulate blood sugar levels. The Pancreatic Diseases drugs in development market research report provide comprehensive information on the therapeutics under development...
-
Product Insights
NewPancreatitis – Drugs In Development, 2024
Empower your strategies with our Pancreatitis – Drugs In Development, 2024 report and make more profitable business decisions. Pancreatitis is an inflammation of the pancreas. Symptoms include nausea, vomiting, tenderness when touching the abdomen, weight loss, and upper abdominal pain. Predisposing factors include alcoholism, smoking, family history of pancreatitis, infection, injury to the abdomen, and pancreatic cancer. Treatment includes antibiotics and medication to relieve pain. The Pancreatitis drugs in development market research report provide comprehensive information on the therapeutics under development...
-
Product Insights
NewRespiratory Distress Syndrome – Drugs In Development, 2024
Empower your strategies with our Respiratory Distress Syndrome – Drugs In Development, 2024 report and make more profitable business decisions. Respiratory distress syndrome (RDS) occurs in babies born early (premature) whose lungs are not fully developed. The earlier the infant is born, the more likely it is for them to have RDS and need extra oxygen and help breathing. It primarily affects premature infants due to insufficient surfactant, a lung-stabilizing substance. Without surfactant, the lungs collapse, causing breathing difficulties. Common in...
-
Product Insights
NewAcute Respiratory Distress Syndrome – Drugs In Development, 2024
Empower your strategies with our Acute Respiratory Distress Syndrome – Drugs In Development, 2024 report and make more profitable business decisions. Acute respiratory distress syndrome (ARDS) occurs when fluid fills up the air sacs in lungs. This leads to low oxygen levels in the blood. Common causes of ARDS include sepsis, inhalation of harmful substances, severe pneumonia, and head or chest injury. Signs and symptoms of ARDS include severe shortness of breath, labored and unusually rapid breathing, low blood pressure, confusion,...
-
Product Insights
Injectable Drug Delivery Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Injectable Drug Delivery Pipeline Market Report Overview Injectable drug delivery devices help administer a drug into a patient’s blood. The Injectable Drug Delivery pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments ·       Sustained Release Injectable...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Mavodelpar sodium in Glycogen Storage Disorders (GSD)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Mavodelpar sodium in Glycogen Storage Disorders (GSD) Drug Details: Mavodelpar sodium (REN-001) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sufentanil Citrate in Post-Operative Pain
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Sufentanil Citrate in Post-Operative Pain Drug Details:Sufentanil citrate (Zalviso, Arx-F01) is anilide derivative acts as an...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SNP-318 in Dementia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SNP-318 in Dementia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SNP-318 in DementiaDrug Details:SNP-318 is under development for the treatment of dementia. The therapeutic...
-
Product Insights
Transmucosal Drug Delivery Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Transmucosal Drug Delivery Pipeline Market Report Overview A Transmucosal drug delivery device is intended for the localized delivery of medications through a mucous membrane. The transmucosal drug delivery pipeline market research report provides comprehensive information about the transmucosal drug delivery pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Key Segment ·      Nasal ·      Vaginal ·      Buccal Delivery ·      Rectal Key Territories ·      The US...